Evidence map›Paper›PMID 39597824›Full record

ReviewJournal of clinical medicine2024

Amyloidosis in Childhood: A Review of Clinical Features and Comparison with Adult Forms.

Giovanni Battista Zamarra, Marina Sandu, Nicholas Caione, Gabriele Di Pasquale, Alessio Di Berardino, Armando Di Ludovico, Saverio La Bella, Francesco Chiarelli, Valentina Cattivera, Jacopo Colella and 1 more

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Giovanni Battista ZamarraDepartment of Pediatrics, L'Aquila University-UNIVAQ, 67100 L'Aquila, Italy.ORCID 0009-0003-9767-3892
Marina SanduDepartment of Pediatrics, L'Aquila University-UNIVAQ, 67100 L'Aquila, Italy.ORCID 0009-0003-5787-004X
Nicholas CaioneDepartment of Pediatrics, L'Aquila University-UNIVAQ, 67100 L'Aquila, Italy.ORCID 0009-0009-4695-4348
Gabriele Di PasqualeDepartment of Pediatrics, L'Aquila University-UNIVAQ, 67100 L'Aquila, Italy.ORCID 0009-0000-3272-2022
Alessio Di BerardinoDepartment of Pediatrics, L'Aquila University-UNIVAQ, 67100 L'Aquila, Italy.ORCID 0009-0008-2949-2797
Armando Di LudovicoDepartment of Pediatrics, "G. D'Annunzio" University, 66100 Chieti, Italy.ORCID 0000-0002-2644-1475
Saverio La BellaDepartment of Pediatrics, "G. D'Annunzio" University, 66100 Chieti, Italy.ORCID 0000-0002-1244-0789
Francesco ChiarelliDepartment of Pediatrics, "G. D'Annunzio" University, 66100 Chieti, Italy.
Valentina CattiveraDepartment of Pediatrics, L'Aquila University-UNIVAQ, 67100 L'Aquila, Italy.
Jacopo ColellaDepartment of Pediatrics, L'Aquila University-UNIVAQ, 67100 L'Aquila, Italy.ORCID 0009-0005-0532-560X
Giulio Di DonatoDepartment of Pediatrics, L'Aquila University-UNIVAQ, 67100 L'Aquila, Italy.ORCID 0000-0002-3979-9265

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyloidosis is a rare multisystem disorder characterized by extracellular accumulation of insoluble fibrils in various organs and tissues. The most common subtype in the pediatric population is systemic reactive amyloidosis, typically developing secondary to chronic inflammatory conditions and resulting in deposition of serum amyloid A protein in association with apolipoprotein HDL3. Clinical presentation is highly variable and is mostly influenced by specific organs involved, precursor protein type, and extent of amyloid deposition, often closely reflecting clinical features of the underlying disease. The most critical determinants of prognosis are cardiac and renal involvement. Diagnosis of amyloidosis is confirmed by tissue biopsy, which remains the gold standard, followed by precise amyloid fibril typing. The primary therapeutic approach is directed towards controlling underlying disease and reducing serum levels of precursor proteins to prevent further amyloid deposition. This study aims to highlight the main clinical characteristics of amyloidosis with onset in childhood, emphasizing the key differences compared to adult form.

Indexed as

amyloidosismisfolded proteinspediatrics

Identifiers

PMID39597824
PMCPMC11594867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.